PharmAbcine's U.S. Subsidiary, Wincal Biopharm, Presented Preclinical Data on Eye Drops from its Proprietary OPC Platform at ARVO 2024

/PRNewswire/ -- PharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ: 208340), a clinical-stage public company developing next generation therapeutics to...

Related Keywords

Daejeon , Taejon Gwangyoksi , South Korea , Venice Chiueh , Taeweon Lee , Wincal Biopharm Inc , Association For Research , Pharmabcine Inc , Wincal Biopharm , Ocular Penetration Carrier , Chief Scientific Officer ,